| mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-05 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-05 |
| mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-05 |
| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-05 |
| mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-05 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-05 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-05 |
| mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.26 |
8e-05 |
| mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-05 |